CD276 and non-small cell lung carcinoma: The mRNA and protein levels of B7-H3 in non-small-cell lung cancer cells treated with AS-IV and cisplatin decreased significantly, which indicated that AS-IV (dose 5 ng/mL) significantly down-regulated the expression of B7-H3 and increased the sensitivity to cisplatin (He et al., 2016).